Recently, microRNAs (miRNAs or miRs) have been found to play a role in the pathogenesis of rheumatoid arthritis (RA). The expression levels of miRNAs vary in different cell types and thus, the function of miRNAs should be distinct depending on the type and status of the cell. Inflammatory signals induce the expression of some specific miRNAs, such as miR-146a and miR-155, which are known to be up-regulated in the synovium in RA. These miRNAs presumably play a role in RA pathogenesis by regulating the inflammatory status. However, the precise functions of each miRNA in the pathogenesis of RA remain to be discovered. Generation of conventional knockout mice for each miRNA has been a rate-limiting step in gaining further insights into the role of miRNAs in arthritis and autoimmune diseases. However, recent developments in gene editing technologies, such as TALEN (transcription activator-like effector nuclease) and CRISPR/Cas9 systems, allowed the generation of precisely targeted miRNA knockout mice within a short time and at a cheaper cost, thereby accelerating in vivo studies of miRNA functions. These new technologies have allowed a more systematic and comprehensive analysis of the role of miRNAs in RA. This will lead to a better understanding of RA pathogenesis and, hopefully, to a discovery of new molecular targets for RA therapy.
Introduction
However, the precise role of miRNAs in the development of arthritis is still largely unknown, partly because it is difficult to generate knockout mice for each individual miRNA, but also due to problems in the delivery of therapeutic mimetics and inhibitors of miRNAs. Recently, novel genome editing methods, such as TALEN and CRISPR/Cas9 system, have been developed and successfully utilized in the generation of mouse knockouts 3, 4) . These new methods can significantly shorten the time required to make a novel miRNA knockout mouse line. In this review, we summarize the recent findings concerning the roles of miRNAs in RA and introduce a new strategy for miRNA research using the gene editing technique. 10, 11) . MiR-146a is an antiinflammatory mediator because its major target genes are TRAF6 and IRAK1 that mediate inflammatory signals 12) .
Essential role of miRNAs in T cells
Three prime-UTR of TRAF6 has four binding sequences MiR-155 knockout mice developed neither synovial inflammation nor cartilage or bone destruction after the collagen immunization unlike miR-146a deficiencies 13, 14) .
Th17 cytokines IL-17 and IL-22 were found to be significant- MiRNA profiles are different in naïve Tregs and memory
Tregs derived from patients with RA, so the miRNA signature can predict the Treg phenotype 16) .
Other miRNAs in RA pathogenesis
In addition to miR-146a and miR-155, many other miRNAs have been reported to be up-or down-regulated in RA synovium (Refs. 1, 2, Fig.1 ). Almost all RA related miRNAs were expressed in PBMC or fibroblast-like synoviocytes
(FLS). MiR-451 is expressed in neutrophils and is unique
as it does not require Dicer for its maturation process 17, 18) .
MiR-451 expression in neutrophils isolated from patients with RA was lower than that in healthy controls 19) . .
In addition to miRNAs within intact cells, circulating miRNAs in RA patients are reported to be potential markers of disease progression. The expression of both miR-16 and miR-223 in sera were not significantly different between established RA and HC. However, both miR-16 and miR-223 could be predictors for the disease outcome in only early RA 23) . At this moment, it is unclear how these circulating miRNAs are involved into RA pathogenesis.
TALEN and CRISPR/Cas9 system for miRNA knockout
Human miRNAs are coded in intragenic (1072 miRNAs) or intergenic (799 miRNAs) regions of protein-coding genes 24) .
Intragenic miRNA contains intronic and exonic miRNAs. These two mature miRNAs have the same sequence.
MiR-24-1 is intronic (rho=0.9), whereas miR-24-2 is an intergenic miRNA. MiR-133a also comprises two miRNAs derived from distinct genomic loci: miR-133a-1 is intronic CRISPR/cas9 system also delete large-scale genome 27) .
TALEN and CRISPR/cas9 systems enable short/long editing of genome for the generation of genome-modified animals to clarify function of miRNAs. We expect that the number of studies using miRNA knockout mice created by means of the TALEN and CRISPR/cas9 system will undoubtedly increase in the near future.
Summary
Expression of specific miRNAs in RA has been demonstrated by many studies. Among them, the function of some miRNAs gradually have become clear in inflammatory conditions. However, the role of these miRNAs in the pathogenesis of RA is still largely unknown. To clarify the role of miRNAs in RA pathogenesis, it is important to identify miRNA-target genes interactions and the function of miRNAs in various cell types. TALEN or CRISPR/cas9 systems could be powerful technology to clarify the function of miRNAs. 
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